Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial by Mullen, M, Jin, X, Child, A, Hu, J

Assessment of carotid compliance using real time vascular ultrasound image analysis in Marfan syndrome by Kiotsekoglou, A, Newey, V, Bajpai, A, Bijnens, B, Kapetanakis, B, Halliday, A, Nassiri, D, Camm, J, Sutherland, G, Child, A

A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol. by Mullen, M, Flather, MD, Jin, X, Newman, W, Erdem, G, Gaze, D, Valencia, O, Banya, W, Foley, C, Child, A

Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. by Bown, M, Jones, G, Harrison, S, Wright, B, Bumpstead, S, Baas, A, Gretarsdottir, S, Badger, SA, Bradley, D, Burnand, K, Child, A, Clough, R, Cockerill, G, Hafez, H, Scott, D, Futers, S, Johnson, A, Sohrabi, S, Smith, A, Thompson, M, van Bockxmeer, F, Waltham, M, Matthiasson, SE, Thorleifsson, G, Thorsteinsdottir, U